Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long extinct species.
Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.